Rhythm Pharmaceuticals Files 2024 Annual Report
Ticker: RYTM · Form: 10-K · Filed: Feb 28, 2025 · CIK: 1649904
| Field | Detail |
|---|---|
| Company | Rhythm Pharmaceuticals, Inc. (RYTM) |
| Form Type | 10-K |
| Filed Date | Feb 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals, financials
TL;DR
RYTM 10-K filed: Full 2024 financials out. Check for stock activity.
AI Summary
Rhythm Pharmaceuticals, Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, headquartered in Boston, MA, operates in the Pharmaceutical Preparations sector. Key financial activities and stock-related events are detailed within the filing, including information on common stock and preferred stock transactions.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Rhythm Pharmaceuticals' financial performance and operational status for the past fiscal year, crucial for understanding the company's health and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Rhythm Pharmaceuticals faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in their 10-K filing.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-02-28 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- RHYTHM PHARMACEUTICALS, INC. (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-02-28 (date) — Filing Date
- 222 BERKELEY STREET (address) — Business Address
- BOSTON (location) — Business City
- DE (location) — State of Incorporation
- 0001649904 (company_id) — Central Index Key
FAQ
What was Rhythm Pharmaceuticals' primary business focus during the fiscal year 2024?
The filing indicates Rhythm Pharmaceuticals, Inc. operates in the Pharmaceutical Preparations sector (SIC code 2834).
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on February 28, 2025.
What is the company's principal executive office address?
The company's business address is 222 Berkeley Street, 12th Floor, Boston, MA 02116.
What type of stock transactions are mentioned in the filing for the period of January 1, 2024, to December 31, 2024?
The filing mentions 'At Market Offerings' related to common stock and additional paid-in capital during this period.
Has the company undergone any name changes?
Yes, the company was formerly known as RHYTHM METABOLIC, INC., with a name change date of August 3, 2015.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 28, 2025 regarding RHYTHM PHARMACEUTICALS, INC. (RYTM).